目的：可溶性HLAA2 抗原肽复合物的体外折叠复性与生物素化。
AIM: To refold and biotinylate HLA A2 peptide complex in vitro .
目的探讨从神经胶质瘤细胞中提取热休克蛋白抗原肽复合物(HAC)的方法。
Objective To investigate the methods for extraction of heat shock protein antigen complex (HAC) from glioma cells.
对B27与抗原肽复合物晶体结构的研究表明，B27与抗原肽结合具有特异性和可塑性，不同亚型具有不同的结合特点。
Research about crystal structure of HLA-B27-peptide complexes suggested the specificity and plasticity of peptide-binding and subtypes dependent binding features.
嗜酸性粒细胞通过趋化作用对过敏反应中的组胺、免疫复合物和嗜酸性粒细胞趋化因子（肥大细胞脱粒肽）做出反应。
They respond chemotactically to histamine, immune complexes, and eosinophil chemotactic factor of anaphylaxis, a substance released by degranulating mast cells.
细胞只能识别抗原提呈细胞表面特定的抗原肽MHC分子复合物，这就是T细胞抗原识别的MHC限制。
T cell can only recognize specific antigenic peptide-MHC complex on antigen-presenting cell. This is MHC restriction in antigen recognition of t cell.
方法：以TRF1抗体应用免疫共沉淀方法，从细胞蛋白抽提物中分离TRF1蛋白复合物，并作蛋白质肽指纹谱鉴定；
Methods: The co immunoprecipitation assay was employed to isolate TRF1 protein complex and the immunoprecipitate was subjected to MALDI TOF mass spectrometry for protein identification.
淋巴细胞识别由主要组织相容性复合物（MHC）I或II类分子递呈的抗原肽片段。
T lymphocytes recognize antigenic peptide fragments presented by major histocompatibility complex(MHC) class I or class II molecules.
嗜酸性粒细胞通过趋化作用对过敏反应中的组胺、免疫复合物和嗜酸性粒细胞趋化因子（肥大细胞脱粒肽）做出反应。
They respond chemotactically to histamine, immune complexes, and eosinophil chemotactic factor of anaphylaxis , a substance released by degranulating mast cells.
描述了包括总共具有15个组件的聚酮化合物合酶、具有1个组件的非核糖体肽合成酶和细胞色素P 450羟化酶组成的聚酮化合物合酶复合物。
A polyketide synthase complex composed of polyketide synthase with 15 total modules, a non-ribosomal peptide synthetase with I module, and a cytochrome P450 hydroxylase is described.
方法采用酶联免疫分析法测定凝血酶原片段1+2 （F1+2 ）、纤维蛋白肽A（FPA）、可溶性纤维蛋白单体复合物（SFMC） ；
Methods Prothrombin fragments 1 and 2 (F1+2), fibrinopeptide A (FPA), soluble fibrin monomer complex(SFMC) were examined by enzyme linked immunoassay(ELISA);
本发明还涉及特异于所述肽的抗体及这些抗体与所述肽的免疫复合物。
This invention also relates to antibodies specific for the peptides and to immune complexes of these antibodies with the peptides.
本发明还涉及特异于所述肽的抗体及这些抗体与所述肽的免疫复合物。
This invention also relates to antibodies specific for the peptides and to immune complexes of these antibodies with the peptides.
应用推荐